Dr. Ashwin Dalal Explains Rare Genetic Diseases in India

Dr. Ashwin Dalal Explains Rare Genetic Diseases in India

🎙 Genetic Education 👥 528 📅 October 17, 2025 ⏱ 23 min 👁 134 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

rare diseasesgenetic disordersIndianovel gene discoveryNational Genomics Core

Summary

In this podcast, Dr. Ashwin Dalal, head of diagnostics at the Centre for DNA Fingerprinting and Diagnostics (CDFD) in India, discusses the landscape of rare genetic diseases in India. He explains that while over 7,000 genetic diseases are known, only about 7,000 of the ~19,500 genes have known disease associations, leaving many patients undiagnosed. He describes the National Mission Program for Pediatric Rare Genetic Disorders, a collaborative effort involving 16 institutes, which has sequenced over 2,000 families and identified several novel genes. Dr. Dalal shares his experience discovering the BHLHA9 gene, which causes limb malformations, and highlights the importance of functional validation using model organisms. He also discusses the burden of rare diseases in India, estimating around 7 crore (70 million) patients, and the government’s initiatives such as the National Rare Disease Policy 2021 and the establishment of Centers of Excellence. A notable anecdote involves a patient with ADCY5-related movement disorder whose symptoms were alleviated by caffeine, illustrating the potential of simple treatments based on genetic insights. Finally, he introduces the National Genomics Core, a facility providing affordable sequencing services to researchers and students.

184 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides valuable insights into the current state of rare disease research and diagnostics in India, highlighting the challenges and opportunities. Dr. Dalal’s arguments are well-structured and supported by his extensive experience and concrete examples, such as the novel gene discovery and the coffee anecdote. He effectively communicates the importance of genetic research and the need for collaborative efforts. The discussion is persuasive and credible, though it relies more on anecdotal evidence than on systematic data presentation.

87 words

Title / Content Match

The title accurately reflects the content, which focuses on rare genetic diseases in India as explained by Dr. Ashwin Dalal.

Quality & Reliability

8/10

The video features a highly qualified expert (Dr. Ashwin Dalal) with extensive experience in medical genetics. The information is presented clearly and is consistent with established knowledge in the field. However, the discussion is largely anecdotal and lacks detailed references to specific studies or data, which slightly reduces the score.

Chapters

Cited Sources

Concurring Sources

  • National Rare Disease Policy 2021 — The policy document mentioned in the video, supporting the discussion on government initiatives.

Contribution & Novelties

The video offers a unique perspective on rare genetic diseases in India, emphasizing the importance of novel gene discovery and the role of national initiatives. It provides practical insights for researchers and clinicians, and highlights the potential of simple treatments based on genetic understanding. The discussion on the National Genomics Core is particularly informative for those interested in accessing sequencing facilities.

Pour aller plus loin :

  • National Rare Disease Policy 2021 (India) — Official policy document outlining the government’s approach to rare diseases.
  • BHLHA9 gene - OMIM — Entry for the BHLHA9 gene, associated with mesoaxial synostotic syndactyly with phalangeal reduction.
  • ADCY5-related dyskinesia - GeneReviews — Comprehensive review of ADCY5-related movement disorders, including the role of caffeine.

117 words

Radar Profile

The radar profile shows high scores in quality of information and technical level, indicating a content-rich and expert-driven discussion. The quantity of information is moderate, and the global reliability is strong, reflecting the credibility of the speaker and the alignment with established knowledge.

Reliability 8/10